ConductScience.org, home
APOBEC3A: apolipoprotein B mRNA editing enzyme catalytic subunit 3A
API referenceFor AI assistants

Gene · 200315

NIH grants1,523

NIH grants whose papers are about the gene, through NIH's grant-paper links.

61 to 80 of 1,523

Download this page as JSON
GrantTitleAPOBEC3A papersNewest fiscal year
P30CA047904Cancer Center Support Grant22025
P30CA076292Moffitt Cancer Center Support Grant22025
P30CA168524The University of Kansas Cancer Center22025
P50CA097190Head and Neck Cancer SPORE22025
P50CA116201Mayo Clinic Breast Cancer SPORE22025
P50CA196530Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer22025
R01AI134818The Role of HBeAg in HBV Persistence22025
R01CA142861Renewal: HPV and the DNA Damage Response22025
R01ES030575Function of HMCES in abasic site repair and tolerance22025
R01HG006677Computational Methods for Gene Discovery, Genome Annotation, and Genome Assembly22025
R01HG012367Sequence-based Machine Learning for Inference of Dynamic Cell State Gene Network Models22025
R21AI185033Role of APOBEC3B in the Innate Immune Response22025
R21ES036190NF-KB regulation by the DNA damage response22025
R35CA263934Understanding and targeting the DNA replication stress in cancer cells22025
R37AI116313Multifaceted interactions between lentiviral Vif and host molecules for viral infectivity enhancement22025
T32AI007140STD and AIDS Research Training Grant22025
T32AI007413Research Training in Experimental Immunology22025
T32AI007417The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program22025
T32CA009523Contemporary Approaches to Cancer Cell Signaling and Communication22025
T32CA009531Training Program in the Biology of Cancer22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/200315/grants?page=4

API referenceFor AI assistants